CCR6 and rheumatoid arthritis: Early studies on the specific blocking of either CCR6 or CCL20 included the transfer of CD4+ T cells from Sakaguchi mice into severe combined immunodeficiency (SCID) mice and the administration of a monoclonal antibody (mAb) against CCR6 in a rheumatoid arthritis model.